Notify me when TIMOTHY A. SPRINGER files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| RNAC | Cartesian Therapeutics, Inc. | Common Stock, $0.0001 par value per share | 37% | $101,956,054 | +$225,969 | 9,555,394 | +0.22% | Timothy A. Springer | 13 Jan 2025 |
| TECX | Tectonic Therapeutic, Inc. | Common Stock, $0.0001 par value per share | 32% | $71,950,147 | +$1,459,500 | 4,313,558 | +2.1% | Timothy A. Springer | 03 Apr 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|